| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |